River BioMedics

BiotechnologySeedEnschede, Netherlandsriverbiomedics.com

Latest round

Seed

Last raised

Jul 2023

Total raised

$4.2M

Investors

4

About River BioMedics

V. operates as a biotechnology company that creates in vitro 3D heart models for future drug discovery. The company offers medical technologies and solutions that include advanced diagnostic tools, therapeutic devices, and medical equipment designed to enhance precision, efficiency, and effectiveness in various medical procedures and treatments. The company’s products and services cater to a diverse range of medical specialties, including cardiology, oncology, neurology, and more.

Who invested in River BioMedics

4 investors across 2 rounds

See all investors in River BioMedics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jul 5, 2023

    Amount

    $2.2M

    Investors

    Locked

  2. Seed

    Jan 20, 2022

    Amount

    $2M

    Investors

    Locked

Questions about River BioMedics

Who invested in River BioMedics?

River BioMedics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has River BioMedics raised?

River BioMedics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did River BioMedics last raise money?

River BioMedics's most recent round on record is a Seed, in Jul 2023.

What does River BioMedics do?

River BioMedics is a biotechnology company.

Where is River BioMedics headquartered?

River BioMedics is headquartered in Enschede, Netherlands.

Which VCs invest in companies like River BioMedics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at River BioMedics's stage. Their profiles are linked below.

Raising like River BioMedics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.